ISCNF - Isracann Biosciences Inc.

Other OTC - Other OTC Delayed Price. Currency in USD
0.2073
+0.0125 (+6.42%)
At close: 3:59PM EDT
Stock chart is not supported by your current browser
Previous Close0.1948
Open0.1950
BidN/A x N/A
AskN/A x N/A
Day's Range0.1900 - 0.2169
52 Week Range0.0753 - 0.9700
Volume1,234,223
Avg. Volume743,613
Market Cap22.572M
Beta (5Y Monthly)N/A
PE Ratio (TTM)N/A
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • Israel Begins Cannabis Exports to Meet Unmet Medical Needs -- CFN Media
    Newsfile

    Israel Begins Cannabis Exports to Meet Unmet Medical Needs -- CFN Media

    Seattle, Washington--(Newsfile Corp. - March 27, 2020) - CFN Media (OTCQB: CNFN), the leading agency and financial media network dedicated to the legalized North American cannabis industry announces publication of an article discussing how Israel has shipped the first cannabis export to the UK, marking a new era in Israeli cannabis.Israel has long been an international center for cannabis research. THC, the psychoactive ingredient in cannabis, and CBD, the plant's predominant non-psychoactive ingredient, were ...

  • Isracann Enters JV for Near-Term Cannabis Farm Production Opportunity in Israel
    GlobeNewswire

    Isracann Enters JV for Near-Term Cannabis Farm Production Opportunity in Israel

    Isracann Biosciences Inc.  (CSE:IPOT) (XFRA:A2PT0E) (ISCNF) (the “Company” or “Isracann”) an Israel-based company focused on becoming a premier low cost, high quality cannabis producer for both domestic and European export sales, is pleased to announce its entry into a joint venture agreement (the “JV Agreement”) resulting in a phased partnership of two near-term farm operations located in the Sharon Plain region of Israel. Today’s announcement positions the Company for revenue generating opportunities earlier than previously planned with the Company’s current development project in Nir Israel.

  • Isracann Completes Executive Site and Prospect Visit in Israel
    GlobeNewswire

    Isracann Completes Executive Site and Prospect Visit in Israel

    Isracann Biosciences Inc.  (CSE:IPOT) (XFRA:A2PT0E) (ISCNF) (the “Company”) an Israel-based company focused on becoming a premier low cost, high quality cannabis producer for both domestic and European export sales, is pleased to provide a summary of activities, actions and opportunities identified during a recent official visit that encompassed extensive travel across Israel.

  • Isracann Receives Project Characterization Report and Engages EU GMP Consultancy
    GlobeNewswire

    Isracann Receives Project Characterization Report and Engages EU GMP Consultancy

    Isracann Biosciences Inc.  (CSE:IPOT) (XFRA:A2PT0E) (ISCNF) (the “Company”) an Israel-based company focused on becoming a premier low cost, high quality cannabis producer for both domestic and European export sales, is pleased to advise it has received the results of its previously commissioned comprehensive project characterization report detailing proposed activities for the development of a licensed cannabis agricultural and processing operation located in Nir, Israel. The report technically examines and addresses all operational activities of the proposed farm and provides clear guidelines to ensure compliance regarding medical Cannabis cultivation and post harvest processing.

  • Isracann Enters MOU for European Distribution
    GlobeNewswire

    Isracann Enters MOU for European Distribution

    Isracann Biosciences Inc.  (CSE:IPOT) (XFRA:A2PT0E) (ISCNF) (the “Company”) an Israel-based business focused on becoming a premier low cost, high quality cannabis producer for both domestic and European export sales is pleased to announce entry into a Memorandum of Understanding (“MOU”) towards a distribution agreement serving key legalized European cannabis markets. Due to commercial practicalities, the currently unnamed distributor has provisionally agreed to enter an understanding with Isracann towards a strategic export and processing opportunity as part of a pending definitive agreement. As part of the agreement, the distributor further asserts it is preparing a regional processing facility designed to meet European Union Good Manufacturing Practice (EU-GMP) as stipulated by the EU as a regulatory requirement for medicinal products.

  • Isracann Provides Year End Review
    GlobeNewswire

    Isracann Provides Year End Review

    VANCOUVER, British Columbia, Dec. 30, 2019 -- Isracann Biosciences Inc.  (CSE: IPOT) (XFRA: A2PT0E) (OTC: ISCNF) (the “Company”) an Israel-based company focused on becoming a.

  • Investors Opening Eyes to Opportunity in Israel Cannabis, Including Exclusive CEO Video Interview Part #2 -- CFN Media
    Newsfile

    Investors Opening Eyes to Opportunity in Israel Cannabis, Including Exclusive CEO Video Interview Part #2 -- CFN Media

    Seattle, Washington--(Newsfile Corp. - December 23, 2019) - CFN Media (OTCQB: CNFN), the leading agency and financial media network dedicated to the North American cannabis industry announces publication of an article discussing Isracann Biosciences (CSE: IPOT) (OTC: ISCNF).There is no country on Earth that has a history steeped in cannabis research like that of Israel. Furthermore, there is no government that is more supportive of medical marijuana research than Israel. Yet, the small country ...

  • Canadian Cannabis Success Being Replayed in Israel Right Now -- CFN Media
    Newsfile

    Canadian Cannabis Success Being Replayed in Israel Right Now -- CFN Media

    Seattle, Washington--(Newsfile Corp. - December 17, 2019) - CFN Media (OTCQB: CNFN), the leading agency and financial media network dedicated to the North American cannabis industry announces publication of an article discussing Isracann Biosciences (CSE: IPOT) (OTC: ISCNF).After experiencing success with the legalization of cannabis in Canada, Darryl Jones was looking for the next big cannabis opportunity. As it happens, that opportunity was 11,000 miles away from Vancouver in Israel. Fast forward and Jones ...

  • Isracann Advances New Partnership with Late Stage Cannabis Farm in Israel
    GlobeNewswire

    Isracann Advances New Partnership with Late Stage Cannabis Farm in Israel

    Isracann Biosciences Inc. (CSE:IPOT) (XFRA:A2PT0E) (ISCNF) (the “Company”) an Israel-based company focused on becoming a premier low cost, high quality cannabis producer for both domestic and European export sales, is pleased to announce it has entered into an MOU for a joint venture with an additional farm property consisting of a late stage buildout of a cannabis cultivation facility in an agricultural centre proximal to several licensed producers (LP’s) west of Be’er Sheva, Israel (the “Be’er Sheva Farm”). Under the joint venture, the Company will capitalize the buildout of the remaining construction in return for an economic interest in the project in compliance with Israeli laws. Terms of the joint venture will be released upon signing of a definitive agreement, which is subject to continued due diligence of the Be’er Sheva Farm by the Company.

  • Isracann Closer to Greenhouse Construction as Israel Cannabis Market Heats Up -- CFN Media
    Newsfile

    Isracann Closer to Greenhouse Construction as Israel Cannabis Market Heats Up -- CFN Media

    Seattle, Washington--(Newsfile Corp. - December 10, 2019) - CFN Media (OTCQB: CNFN), the leading agency and financial media network dedicated to the North American cannabis industry announces publication of an article discussing Isracann Biosciences (CSE: IPOT) (OTC: ISCNF).Israel has long been recognized for its pioneering contributions to research in the medical cannabis field. Recently, the state made its commitment clear to develop the sector by issuing a white paper on the opportunity to invest ...

  • Isracann Advances Cannabis Project Characterization in Israel
    GlobeNewswire

    Isracann Advances Cannabis Project Characterization in Israel

    Isracann Biosciences Inc.  (CSE:IPOT) (XFRA:A2PT0E) (ISCNF) (the “Company”) an Israel-based company focused on becoming a premier low cost, high quality cannabis producer for both domestic and European export sales, is pleased to announce it has received a phase 1 project profile report and has been advised that the project characterization project is fully underway and moving ahead on schedule. As previously announced, Isracann engaged the services of LinC by Growing Smart Ltd., an international agricultural management company with extensive experience and expertise within the cannabis sector in Israel. The firm specializes in the delivery of individually tailored project management and agronomic solutions to select cannabis sector projects and is currently managing 12 cannabis projects worldwide.

  • Israel Writing Playbook to Become Cannabis Gateway to Europe -- CFN Media
    Newsfile

    Israel Writing Playbook to Become Cannabis Gateway to Europe -- CFN Media

    Seattle, Washington--(Newsfile Corp. - November 20, 2019) - CFN Media (OTCQB: CNFN), the leading agency and financial media network dedicated to the North American cannabis industry announces publication of an article discussing Isracann Biosciences Inc. (CSE: IPOT) (OTC Pink: ATLED).With unprecedented expertise in cannabis research and perfect weather conditions for cultivation, it only makes sense that Israeli lawmakers took a global leadership position in January 2019 by green-lighting the export of medical cannabis to ...